Remove 2020 Remove Communication Remove Patient Care
article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The webinar will also cover: How HCP engagement changed for pharma in 2020. How engagement with HCPs will evolve in the future.

article thumbnail

What HCPs think about COVID-19’s impact on cancer

pharmaphorum

COVID-19’s knock-on effect on cancer patients is of concern by HCPs, with delayed or decreased diagnosis seen as a key worry. The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. — Professor Karol Sikora (@ProfKarolSikora) April 22, 2020.

Hospitals 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Roche and PatchAi partner on digital tool for cancer patients

pharmaphorum

Roche and PatchAi have been working together on the Smart Health Companion (SHC), which was launched to oncology and haematology patients in July 2020, and will now step up their collaboration to offer it more widely.

article thumbnail

Microsoft puts AI at heart of digital health strategy with Nuance deal

pharmaphorum

billion deal to buy Nuance Communications and its artificial intelligence platform for speech recognition that is increasingly being used for clinical applications. . Microsoft has made its aspirations in digital health clear with a whopping $19.7

article thumbnail

Clinical research in 2021: A new era of collaboration and innovation

pharmaphorum

That said, while industry is already scrutinised from within, increased public pressure for transparency will require all clinical trial experts (including regulators) to communicate proactively with the public. Fortunately, many of the issues in this space are due to very fixable communication deficiencies.

article thumbnail

FDA holds back from action over Xeljanz safety study

pharmaphorum

billion in the first nine months of 2020, up 10% overall and 23% in ex-US markets. We will communicate our final conclusions and recommendations when we have completed our review or have more information to share.”. First approved in 2o12, Xeljanz brought in sales of more than $1.7

FDA 78
article thumbnail

How Pharmacists Can Manage Stress and Maximize Efficiency

Digital Pharmacist

This automated system can help minimize the amount of time your staff has to spend on the phone, enabling patients to refill and transfer prescriptions and get essential pharmacy information. Streamline patient communication on a secure platform that helps you send reminders, share images, and contact patients quickly and easily.

HIPAA 98